首页 > 最新文献

AJOG global reports最新文献

英文 中文
Racial/ethnic disparity in severe maternal morbidity among women who conceived by in vitro fertilization 体外受精受孕妇女严重孕产妇发病率的种族/族裔差异
Pub Date : 2024-06-19 DOI: 10.1016/j.xagr.2024.100367
Jenna Victory MSc , Sid John MSc , Li Qing Wang PhD , Johanna Koegl MD , Lindsay L Richter MSc , Hamideh Bayrampour PhD , K.S. Joseph MD, PhD , Sarka Lisonkova MD, PhD

Background

In vitro fertilization (IVF) as a fertility treatment is associated with adverse perinatal outcomes. Racial/ethnic disparity in severe maternal morbidity (SMM) in women who conceived by IVF is understudied.

Objective

To examine differences in the association between race/ethnicity and SMM between women who conceived spontaneously and those who conceived using IVF.

Methods

We included all singleton live births and stillbirths in the United States, 2016–2021; data were obtained from the National Center for Health Statistics. Maternal race/ethnicity included non-Hispanic White (NHW), non-Hispanic Black (NHB), American Indian and Alaska Native (AIAN), Asian, Pacific Islander (PI), Hispanic, and mixed-race categories. The SMM composite outcome included eclampsia, uterine rupture, peripartum hysterectomy, blood transfusion, and intensive care unit (ICU) admission. We used logistic regression to adjust for potential confounders (such as age, education, parity, prepregnancy body mass index, smoking during pregnancy, chronic hypertension, and preexisting diabetes) and to assess modification of the association between race/ethnicity and SMM by IVF.

Results

The study population included 21,585,015 women: 52% were NHW, 15% NHB, 0.8% AIAN, 6% Asian, 0.2% PI, 24% Hispanic, and 2% were of mixed race. IVF was used by 183,662 (0.85%) women; the rate of the SMM composite outcome was 18.5 per 1000 deliveries and 7.9 per 1000 deliveries in the IVF and spontaneous conception groups, respectively (unadjusted rate ratio 2.34, 95% confidence interval [CI] 2.26–2.43). In women with spontaneous conception, NHB, Asian and mixed-race women had elevated odds of SMM compared with NHW women (adjusted odds ratio [aOR]=1.39, 95% CI 1.37–1.41; aOR=1.04, 95% CI 1.02–1.07; and aOR=1.42, 95% CI 1.38–1.46, respectively). Racial/ethnic disparities in SMM and its components were not different between the IVF and spontaneous conception groups for the mixed-race category. NHB and Hispanic women had significantly higher aORs for uterine rupture/intrapartum hysterectomy compared with NHW women in the IVF group, while Asian women had a higher aOR for ICU admission compared with NHW women in the IVF group.

Conclusion

Women who conceived by IVF have a greater than two-fold higher risk of SMM and this higher risk is evident across all racial/ethnic groups. However, NHB and Hispanic women who conceived by IVF had a higher risk of uterine rupture/hysterectomy, and Asian women who conceived by IVF had a higher risk of ICU admission. Our results warrant further investigation examining pregnancy and postpartum care issues among racial/ethnic minority women who conceive using IVF.

背景体外受精(IVF)作为一种生育治疗方法与不良围产期结局有关。目的 研究自然受孕和试管婴儿受孕妇女的种族/族裔与严重孕产妇发病率(SMM)之间的差异。方法 我们纳入了 2016-2021 年美国所有单胎活产和死胎;数据来自国家卫生统计中心。产妇的种族/族裔包括非西班牙裔白人(NHW)、非西班牙裔黑人(NHB)、美国印第安人和阿拉斯加原住民(AIAN)、亚裔、太平洋岛民(PI)、西班牙裔和混血儿。SMM 综合结果包括子痫、子宫破裂、围产期子宫切除、输血和入住重症监护室 (ICU)。我们使用逻辑回归调整了潜在的混杂因素(如年龄、教育程度、胎次、孕前体重指数、孕期吸烟、慢性高血压和既往糖尿病),并评估了试管婴儿对种族/民族与 SMM 之间关系的影响。183,662名妇女(0.85%)使用了体外受精;体外受精组和自然受孕组的SMM综合结果发生率分别为每1000例分娩中有18.5例和7.9例(未经调整的比率比为2.34,95%置信区间[CI] 为2.26-2.43)。在自然受孕的妇女中,非华裔、亚裔和混血妇女发生SMM的几率高于非华裔妇女(调整后的几率比[aOR]=1.39,95% CI为1.37-1.41;aOR=1.04,95% CI为1.02-1.07;aOR=1.42,95% CI为1.38-1.46)。在混血类别中,试管受孕组和自然受孕组在 SMM 及其组成部分方面的种族/族裔差异并无不同。与体外受精组的非华裔女性相比,非华裔黑人和西班牙裔女性的子宫破裂/产后子宫切除的 aOR 明显更高,而与体外受精组的非华裔女性相比,亚裔女性入住重症监护室的 aOR 则更高。然而,通过体外受精受孕的非华裔黑人和西班牙裔女性发生子宫破裂/子宫切除术的风险更高,通过体外受精受孕的亚裔女性入住重症监护室的风险更高。我们的研究结果证明,有必要进一步调查使用体外受精受孕的少数种族/族裔妇女的孕期和产后护理问题。
{"title":"Racial/ethnic disparity in severe maternal morbidity among women who conceived by in vitro fertilization","authors":"Jenna Victory MSc ,&nbsp;Sid John MSc ,&nbsp;Li Qing Wang PhD ,&nbsp;Johanna Koegl MD ,&nbsp;Lindsay L Richter MSc ,&nbsp;Hamideh Bayrampour PhD ,&nbsp;K.S. Joseph MD, PhD ,&nbsp;Sarka Lisonkova MD, PhD","doi":"10.1016/j.xagr.2024.100367","DOIUrl":"https://doi.org/10.1016/j.xagr.2024.100367","url":null,"abstract":"<div><h3>Background</h3><p>In vitro fertilization (IVF) as a fertility treatment is associated with adverse perinatal outcomes. Racial/ethnic disparity in severe maternal morbidity (SMM) in women who conceived by IVF is understudied.</p></div><div><h3>Objective</h3><p>To examine differences in the association between race/ethnicity and SMM between women who conceived spontaneously and those who conceived using IVF.</p></div><div><h3>Methods</h3><p>We included all singleton live births and stillbirths in the United States, 2016–2021; data were obtained from the National Center for Health Statistics. Maternal race/ethnicity included non-Hispanic White (NHW), non-Hispanic Black (NHB), American Indian and Alaska Native (AIAN), Asian, Pacific Islander (PI), Hispanic, and mixed-race categories. The SMM composite outcome included eclampsia, uterine rupture, peripartum hysterectomy, blood transfusion, and intensive care unit (ICU) admission. We used logistic regression to adjust for potential confounders (such as age, education, parity, prepregnancy body mass index, smoking during pregnancy, chronic hypertension, and preexisting diabetes) and to assess modification of the association between race/ethnicity and SMM by IVF.</p></div><div><h3>Results</h3><p>The study population included 21,585,015 women: 52% were NHW, 15% NHB, 0.8% AIAN, 6% Asian, 0.2% PI, 24% Hispanic, and 2% were of mixed race. IVF was used by 183,662 (0.85%) women; the rate of the SMM composite outcome was 18.5 per 1000 deliveries and 7.9 per 1000 deliveries in the IVF and spontaneous conception groups, respectively (unadjusted rate ratio 2.34, 95% confidence interval [CI] 2.26–2.43). In women with spontaneous conception, NHB, Asian and mixed-race women had elevated odds of SMM compared with NHW women (adjusted odds ratio [aOR]=1.39, 95% CI 1.37–1.41; aOR=1.04, 95% CI 1.02–1.07; and aOR=1.42, 95% CI 1.38–1.46, respectively). Racial/ethnic disparities in SMM and its components were not different between the IVF and spontaneous conception groups for the mixed-race category. NHB and Hispanic women had significantly higher aORs for uterine rupture/intrapartum hysterectomy compared with NHW women in the IVF group, while Asian women had a higher aOR for ICU admission compared with NHW women in the IVF group.</p></div><div><h3>Conclusion</h3><p>Women who conceived by IVF have a greater than two-fold higher risk of SMM and this higher risk is evident across all racial/ethnic groups. However, NHB and Hispanic women who conceived by IVF had a higher risk of uterine rupture/hysterectomy, and Asian women who conceived by IVF had a higher risk of ICU admission. Our results warrant further investigation examining pregnancy and postpartum care issues among racial/ethnic minority women who conceive using IVF.</p></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"4 3","pages":"Article 100367"},"PeriodicalIF":0.0,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000613/pdfft?md5=33083b59abf6a2b1a5d6dab2f42d2ba6&pid=1-s2.0-S2666577824000613-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141592959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regional disparities in primary cesarean delivery rates in Japan: the role of obstetrician availability 日本初次剖腹产率的地区差异:产科医生供应的作用
Pub Date : 2024-06-18 DOI: 10.1016/j.xagr.2024.100366
Akihiko Ueda MD , Baku Nakakita MD , Yoshitsugu Chigusa MD, PhD , Haruta Mogami MD, PhD , Genta Kato MD, PhD , Hiroaki Ueshima PhD , Masaki Mandai MD, PhD , Eiji Kondoh MD, PhD

Background

The prevalence of cesarean section procedures is on the rise worldwide, necessitating a deeper understanding of the factors driving this trend to mitigate potential adverse consequences associated with unnecessary cesarean section deliveries.

Objectives

This study aims to investigate the rate of primary cesarean deliveries (PCD), a potential key indicator of obstetric care quality.

Study Design

A national retrospective cohort study was conducted utilizing extensive data from the National Database of Health Insurance Claims and Specific Health Checkups of Japan spanning the years 2012 to 2018. The study examined the temporal trends in PCD rates and the indications for these procedures across different prefectures. Additionally, the study employed the obstetrician disproportionality index, as published by the Ministry of Health, Labour, and Welfare, to assess the influence of obstetrician availability on PCD rates.

Results

Throughout the study period from 2012 to 2018, the rate of PCD in Japan remained relatively stable at approximately 14%. The primary indications for PCD in 2018 included labor arrest (18.3%), malpresentation (16.5%), nonreassuring fetal status (6.5%), and macrosomia (6.0%). Substantial regional disparities in PCD rates were observed, ranging from 8.9% to 20.4% among prefectures in 2018. Notably, prefectures categorized in the bottom 10 of the obstetrician disproportionality index exhibited significantly higher PCD rates compared to the top 10 prefectures (P=.0232), with a similar trend noted for PCD due to labor arrest (P=.0288). Furthermore, a negative correlation was identified between the obstetrician disproportionality index and PCD rates at the prefectural level (r=–0.3119, P=.0328).

Conclusions

Our study presents a comprehensive analysis of PCD rates in Japan, shedding light on regional disparities and highlighting the notable influence of obstetrician availability on clinical decision-making. This study contributes to the ongoing discourse on the escalating global trend in cesarean sections and the importance of healthcare resource allocation in maternal care.

背景全世界剖宫产手术的流行率正在上升,因此有必要深入了解推动这一趋势的因素,以减轻与不必要的剖宫产分娩相关的潜在不良后果。研究目的本研究旨在调查初级剖宫产率(PCD),这是衡量产科护理质量的潜在关键指标。该研究考察了各都道府县 PCD 率的时间趋势以及这些手术的适应症。此外,研究还采用了厚生劳动省公布的产科医生比例失调指数,以评估产科医生的可用性对 PCD 率的影响。结果在 2012 年至 2018 年的整个研究期间,日本的 PCD 率保持相对稳定,约为 14%。2018 年 PCD 的主要适应症包括产程停止(18.3%)、胎位不正(16.5%)、胎儿状况无法保证(6.5%)和巨大儿(6.0%)。据观察,2018 年各都道府县的 PCD 发生率存在巨大的地区差异,从 8.9% 到 20.4% 不等。值得注意的是,与排名前 10 的都道府县相比,产科医生比例失调指数排名后 10 的都道府县的 PCD 率明显较高(P=.0232),因停产导致的 PCD 也呈现类似趋势(P=.0288)。此外,在都道府县一级,产科医生比例失调指数与 PCD 率之间存在负相关关系(r=-0.3119,P=.0328)。结论我们的研究对日本的 PCD 率进行了全面分析,揭示了地区差异,并强调了产科医生的可用性对临床决策的显著影响。这项研究为当前有关剖宫产手术全球趋势的讨论以及孕产妇护理中医疗资源分配的重要性做出了贡献。
{"title":"Regional disparities in primary cesarean delivery rates in Japan: the role of obstetrician availability","authors":"Akihiko Ueda MD ,&nbsp;Baku Nakakita MD ,&nbsp;Yoshitsugu Chigusa MD, PhD ,&nbsp;Haruta Mogami MD, PhD ,&nbsp;Genta Kato MD, PhD ,&nbsp;Hiroaki Ueshima PhD ,&nbsp;Masaki Mandai MD, PhD ,&nbsp;Eiji Kondoh MD, PhD","doi":"10.1016/j.xagr.2024.100366","DOIUrl":"10.1016/j.xagr.2024.100366","url":null,"abstract":"<div><h3>Background</h3><p>The prevalence of cesarean section procedures is on the rise worldwide, necessitating a deeper understanding of the factors driving this trend to mitigate potential adverse consequences associated with unnecessary cesarean section deliveries.</p></div><div><h3>Objectives</h3><p>This study aims to investigate the rate of primary cesarean deliveries (PCD), a potential key indicator of obstetric care quality.</p></div><div><h3>Study Design</h3><p>A national retrospective cohort study was conducted utilizing extensive data from the National Database of Health Insurance Claims and Specific Health Checkups of Japan spanning the years 2012 to 2018. The study examined the temporal trends in PCD rates and the indications for these procedures across different prefectures. Additionally, the study employed the obstetrician disproportionality index, as published by the Ministry of Health, Labour, and Welfare, to assess the influence of obstetrician availability on PCD rates.</p></div><div><h3>Results</h3><p>Throughout the study period from 2012 to 2018, the rate of PCD in Japan remained relatively stable at approximately 14%. The primary indications for PCD in 2018 included labor arrest (18.3%), malpresentation (16.5%), nonreassuring fetal status (6.5%), and macrosomia (6.0%). Substantial regional disparities in PCD rates were observed, ranging from 8.9% to 20.4% among prefectures in 2018. Notably, prefectures categorized in the bottom 10 of the obstetrician disproportionality index exhibited significantly higher PCD rates compared to the top 10 prefectures (<em>P</em>=.0232), with a similar trend noted for PCD due to labor arrest (<em>P</em>=.0288). Furthermore, a negative correlation was identified between the obstetrician disproportionality index and PCD rates at the prefectural level (<em>r</em>=–0.3119, <em>P</em>=.0328).</p></div><div><h3>Conclusions</h3><p>Our study presents a comprehensive analysis of PCD rates in Japan, shedding light on regional disparities and highlighting the notable influence of obstetrician availability on clinical decision-making. This study contributes to the ongoing discourse on the escalating global trend in cesarean sections and the importance of healthcare resource allocation in maternal care.</p></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"4 3","pages":"Article 100366"},"PeriodicalIF":0.0,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000601/pdfft?md5=3e029750fd690072b813496984771bcb&pid=1-s2.0-S2666577824000601-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141630405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of planned delivery mode on neonatal outcomes and costs in twin pregnancies in Kenya 肯尼亚双胎妊娠中计划分娩方式对新生儿预后和成本的影响
Pub Date : 2024-06-18 DOI: 10.1016/j.xagr.2024.100370
Fred O. Omondi MBChB , Meghan K. Murphy DO , Moselle M. Stark MD , Cheryl B. Cowles MD , Phillip C. Greig MD , Benoît J. Ndikumana MMed (Obs & Gyn) , Robert K. Parker MD, MPH

Background

Twin pregnancies are associated with higher risks of adverse neonatal outcomes compared to singleton pregnancies. The choice of delivery mode, when twin A presents cephalic, remains a subject of debate. In low- and middle-income countries, where healthcare resources are limited, the decision on the mode of delivery is even more critical.

Objective

To evaluate the neonatal outcomes and the hospital costs of planned vaginal delivery compared to cesarean section (CS) in twin pregnancies with twin A presenting cephalic at Tenwek Hospital, Kenya.

Study Design

This retrospective cohort study analyzed data from all twin deliveries at Tenwek Hospital, Kenya from, April 1, 2017, to March 30, 2023. Maternal data, mode of delivery, and neonatal data were collected from delivery logs, electronic health records, and neonatal records. Neonatal outcomes were a composite of either Appearance, Pulse, Grimace, Activity, and Respiration score less than seven at 5 minutes, neonatal intensive care unit admission, resuscitation, birth trauma, or neonatal complications, including death before discharge from the hospital. A logistic regression model was created to assess the impact of the planned mode of delivery on neonatal outcomes, controlling for antenatal care clinic visits, noncephalic presentation of twin B, and birth weight category.

Results

The study included 177 twin deliveries: 129 (72.9%) were planned as vaginal deliveries and 48 (27.1%) were planned for CS. Among the planned vaginal deliveries, 66 (51.2%) experienced adverse outcomes, compared to 14 (29.2%) in the CS group (P=.009). Logistic regression showed that the odds of adverse outcomes were 0.35 times lower in the CS group compared to the planned vaginal delivery group (95% CI: 0.15–0.83; P=.017). The average total hospital costs for planned vaginal delivery were 104,608 Kenya Shillings (standard deviation 111,761) compared to 100,708 Kenya Shillings (standard deviation 75,468) for CS (P=.82).

Conclusion

Planned cesarean deliveries in twin pregnancies with twin A presenting cephalic at Tenwek Hospital were associated with fewer adverse neonatal outcomes compared to planned vaginal deliveries. There was no significant difference in hospital costs. These findings raise the question of the safest mode of delivery for patients in a resource-constrained setting.

背景双胎妊娠与单胎妊娠相比,新生儿不良结局的风险更高。当双胎 A 出现头位时,分娩方式的选择仍是一个争论的话题。研究设计这项回顾性队列研究分析了 2017 年 4 月 1 日至 2023 年 3 月 30 日期间肯尼亚 Tenwek 医院所有双胎分娩的数据。产妇数据、分娩方式和新生儿数据均来自分娩记录、电子健康记录和新生儿记录。新生儿结局是5分钟内外观、脉搏、面色、活动和呼吸评分小于7分、入住新生儿重症监护室、复苏、产伤或新生儿并发症(包括出院前死亡)的综合结果。研究建立了一个逻辑回归模型,以评估计划分娩方式对新生儿预后的影响,同时控制产前护理门诊就诊次数、双胎 B 的非颅型表现和出生体重类别:129例(72.9%)计划阴道分娩,48例(27.1%)计划CS分娩。在计划阴道分娩的产妇中,66例(51.2%)出现不良结局,而CS组中有14例(29.2%)(P=0.009)。逻辑回归显示,与计划阴道分娩组相比,CS 组发生不良后果的几率低 0.35 倍(95% CI:0.15-0.83;P=.017)。Tenwek医院的双胎妊娠中,双胎A呈头位的计划剖宫产与计划阴道分娩相比,新生儿不良结局较少。住院费用没有明显差异。这些研究结果提出了一个问题:在资源有限的情况下,患者采用哪种分娩方式最安全?
{"title":"Impact of planned delivery mode on neonatal outcomes and costs in twin pregnancies in Kenya","authors":"Fred O. Omondi MBChB ,&nbsp;Meghan K. Murphy DO ,&nbsp;Moselle M. Stark MD ,&nbsp;Cheryl B. Cowles MD ,&nbsp;Phillip C. Greig MD ,&nbsp;Benoît J. Ndikumana MMed (Obs & Gyn) ,&nbsp;Robert K. Parker MD, MPH","doi":"10.1016/j.xagr.2024.100370","DOIUrl":"10.1016/j.xagr.2024.100370","url":null,"abstract":"<div><h3>Background</h3><p>Twin pregnancies are associated with higher risks of adverse neonatal outcomes compared to singleton pregnancies. The choice of delivery mode, when twin A presents cephalic, remains a subject of debate. In low- and middle-income countries, where healthcare resources are limited, the decision on the mode of delivery is even more critical.</p></div><div><h3>Objective</h3><p>To evaluate the neonatal outcomes and the hospital costs of planned vaginal delivery compared to cesarean section (CS) in twin pregnancies with twin A presenting cephalic at Tenwek Hospital, Kenya.</p></div><div><h3>Study Design</h3><p>This retrospective cohort study analyzed data from all twin deliveries at Tenwek Hospital, Kenya from, April 1, 2017, to March 30, 2023. Maternal data, mode of delivery, and neonatal data were collected from delivery logs, electronic health records, and neonatal records. Neonatal outcomes were a composite of either Appearance, Pulse, Grimace, Activity, and Respiration score less than seven at 5 minutes, neonatal intensive care unit admission, resuscitation, birth trauma, or neonatal complications, including death before discharge from the hospital. A logistic regression model was created to assess the impact of the planned mode of delivery on neonatal outcomes, controlling for antenatal care clinic visits, noncephalic presentation of twin B, and birth weight category.</p></div><div><h3>Results</h3><p>The study included 177 twin deliveries: 129 (72.9%) were planned as vaginal deliveries and 48 (27.1%) were planned for CS. Among the planned vaginal deliveries, 66 (51.2%) experienced adverse outcomes, compared to 14 (29.2%) in the CS group (<em>P</em>=.009). Logistic regression showed that the odds of adverse outcomes were 0.35 times lower in the CS group compared to the planned vaginal delivery group (95% CI: 0.15–0.83; <em>P</em>=.017). The average total hospital costs for planned vaginal delivery were 104,608 Kenya Shillings (standard deviation 111,761) compared to 100,708 Kenya Shillings (standard deviation 75,468) for CS (<em>P</em>=.82).</p></div><div><h3>Conclusion</h3><p>Planned cesarean deliveries in twin pregnancies with twin A presenting cephalic at Tenwek Hospital were associated with fewer adverse neonatal outcomes compared to planned vaginal deliveries. There was no significant difference in hospital costs. These findings raise the question of the safest mode of delivery for patients in a resource-constrained setting.</p></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"4 3","pages":"Article 100370"},"PeriodicalIF":0.0,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000649/pdfft?md5=1e7004f4c1399c0ceff463f32afe1c91&pid=1-s2.0-S2666577824000649-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141623319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A gluten-free diet for endometriosis patients lacks evidence to recommend it 子宫内膜异位症患者的无麸质饮食缺乏推荐证据
Pub Date : 2024-06-18 DOI: 10.1016/j.xagr.2024.100369
Annelotte P. van Haaps MD , Fred Brouns MD , Anneke M.F. Schreurs MD, PhD , Daniel Keszthelyi MD PhD , Jacques W.M. Maas MD, PhD , Velja Mijatovic MD, PhD

Endometriosis is an estrogen-dependent chronic disease characterized by the presence of endometriumlike tissue outside the uterus and is often associated with symptoms, such as dysmenorrhea, dysuria, dyschezia, chronic pelvic pain, and infertility. Moreover, women diagnosed with endometriosis can report gastrointestinal symptoms, including bloating, constipation or diarrhea, and abdominal cramping, which can be associated with irritable bowel syndrome and can result in the misdiagnosis of endometriosis as irritable bowel syndrome at first. Treatment usually involves hormonal therapy, pain management, surgery, and/or assisted reproductive techniques in case of infertility. Nonetheless, these treatment methods can be insufficient for alleviating symptoms or can have unacceptable side effects, leading to noncompliance. Therefore, women often apply self-management strategies, including dietary interventions.

One of the diets frequently suggested as a tool to manage endometriosis-related symptoms on social media and patient forums is a gluten-free diet. Although a gluten-free diet has been proven effective in managing nonceliac wheat sensitivity or celiac disease, its effectiveness in endometriosis remains uncertain. The Nurses’ Health Study II found it unlikely that gluten intake was a strong factor in endometriosis etiology and symptomatology. To the best of our knowledge, the most frequently cited and sole published intervention study on the efficacy of a gluten-free diet for endometriosis has several important limiting factors, including the absence of a control group. In addition, gluten consumption is highly susceptible to a placebo effect and a nocebo effect, where women might experience symptom relief after eliminating gluten and return of symptoms after they consume gluten again, solely because they believe that gluten is bad for them. Despite the inverse association between body mass index and endometriosis and between a gluten-free diet and increased body mass index, this is an association, and no causality was proven. In addition, other factors should be taken into consideration.

Of note, a gluten-free diet is expensive, has limited availability, and has a significant effect on quality of life. Moreover, without proper dietary guidance, it may adversely affect the gastrointestinal microbiome. Therefore, scientifically substantiated advice regarding the use of a gluten-free diet for endometriosis-related symptoms is currently not available, and a gluten-free diet should be discouraged unless there is an additional diagnosis of nonceliac wheat sensitivity or celiac disease.

子宫内膜异位症是一种雌激素依赖性慢性疾病,其特征是子宫腔外存在子宫内膜样组织,通常伴有痛经、排尿困难、月经失调、慢性盆腔疼痛和不孕等症状。此外,确诊为子宫内膜异位症的妇女可能会出现胃肠道症状,包括腹胀、便秘或腹泻、腹部绞痛等,这些症状可能与肠易激综合征有关,可能导致子宫内膜异位症一开始被误诊为肠易激综合征。治疗通常包括激素治疗、止痛、手术和/或不孕症辅助生殖技术。然而,这些治疗方法可能不足以缓解症状,或者会产生令人无法接受的副作用,从而导致患者不配合治疗。在社交媒体和患者论坛上,人们经常建议将无麸质饮食作为控制子宫内膜异位症相关症状的工具之一。虽然无麸质饮食已被证明能有效控制非乳糜泻性小麦敏感症或乳糜泻,但其对子宫内膜异位症的效果仍不确定。护士健康研究 II》(Nurses' Health Study II)发现,麸质摄入量不太可能是导致子宫内膜异位症病因和症状的重要因素。据我们所知,关于无麸质饮食对子宫内膜异位症疗效的最常引用和唯一发表的干预研究有几个重要的限制因素,包括缺乏对照组。此外,食用麸质食品极易产生安慰剂效应和安慰剂效应,即妇女在剔除麸质食品后症状可能得到缓解,而在再次食用麸质食品后症状又会恢复,这完全是因为她们认为麸质食品对她们有害。尽管体重指数与子宫内膜异位症之间以及无麸质饮食与体重指数增加之间存在反向关联,但这只是一种关联,并不能证明因果关系。此外,还应考虑其他因素。值得注意的是,无麸质饮食价格昂贵,供应有限,对生活质量有很大影响。此外,如果没有正确的饮食指导,可能会对胃肠道微生物群产生不利影响。因此,关于使用无麸质饮食治疗子宫内膜异位症相关症状的建议目前尚无科学依据,除非有非乳糜泻性小麦敏感症或乳糜泻的附加诊断,否则不建议使用无麸质饮食。
{"title":"A gluten-free diet for endometriosis patients lacks evidence to recommend it","authors":"Annelotte P. van Haaps MD ,&nbsp;Fred Brouns MD ,&nbsp;Anneke M.F. Schreurs MD, PhD ,&nbsp;Daniel Keszthelyi MD PhD ,&nbsp;Jacques W.M. Maas MD, PhD ,&nbsp;Velja Mijatovic MD, PhD","doi":"10.1016/j.xagr.2024.100369","DOIUrl":"https://doi.org/10.1016/j.xagr.2024.100369","url":null,"abstract":"<div><p>Endometriosis is an estrogen-dependent chronic disease characterized by the presence of endometriumlike tissue outside the uterus and is often associated with symptoms, such as dysmenorrhea, dysuria, dyschezia, chronic pelvic pain, and infertility. Moreover, women diagnosed with endometriosis can report gastrointestinal symptoms, including bloating, constipation or diarrhea, and abdominal cramping, which can be associated with irritable bowel syndrome and can result in the misdiagnosis of endometriosis as irritable bowel syndrome at first. Treatment usually involves hormonal therapy, pain management, surgery, and/or assisted reproductive techniques in case of infertility. Nonetheless, these treatment methods can be insufficient for alleviating symptoms or can have unacceptable side effects, leading to noncompliance. Therefore, women often apply self-management strategies, including dietary interventions.</p><p>One of the diets frequently suggested as a tool to manage endometriosis-related symptoms on social media and patient forums is a gluten-free diet. Although a gluten-free diet has been proven effective in managing nonceliac wheat sensitivity or celiac disease, its effectiveness in endometriosis remains uncertain. The Nurses’ Health Study II found it unlikely that gluten intake was a strong factor in endometriosis etiology and symptomatology. To the best of our knowledge, the most frequently cited and sole published intervention study on the efficacy of a gluten-free diet for endometriosis has several important limiting factors, including the absence of a control group. In addition, gluten consumption is highly susceptible to a placebo effect and a nocebo effect, where women might experience symptom relief after eliminating gluten and return of symptoms after they consume gluten again, solely because they believe that gluten is bad for them. Despite the inverse association between body mass index and endometriosis and between a gluten-free diet and increased body mass index, this is an association, and no causality was proven. In addition, other factors should be taken into consideration.</p><p>Of note, a gluten-free diet is expensive, has limited availability, and has a significant effect on quality of life. Moreover, without proper dietary guidance, it may adversely affect the gastrointestinal microbiome. Therefore, scientifically substantiated advice regarding the use of a gluten-free diet for endometriosis-related symptoms is currently not available, and a gluten-free diet should be discouraged unless there is an additional diagnosis of nonceliac wheat sensitivity or celiac disease.</p></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"4 3","pages":"Article 100369"},"PeriodicalIF":0.0,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000637/pdfft?md5=d7f1c3604216cb6e7b35f6c151cfbcc0&pid=1-s2.0-S2666577824000637-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141541326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving health equity through sustained academic partnership: development of a maternal-fetal medicine fellowship training program in Western Kenya 通过持续的学术合作改善健康公平:在肯尼亚西部开展母胎医学研究员培训计划。
Pub Date : 2024-06-14 DOI: 10.1016/j.xagr.2024.100362
David Nding'ori MMed , Rachel F. Spitzer MD, MPH , Julia Songok MMed , Marie Buitendyk MD, MSc , Pallavi Mishra MMed , Wycliffe Kosgei MMed , Bett Kipchumba MMed , Mutindi Kakuti MMed , Philip Tonui MMed , Karen Fung-Kee-Fung MD, MHPE , Heidi Leftwich DO , Adrian Gardner MD, MPH , Paul Nyongesa MMed , Nanette Okun MD, MHsc

Low- and middle-income countries are underresourced in subspecialist care. This study describes a unique maternal-fetal medicine clinical fellowship training program at Moi University School of Medicine and Moi Teaching and Referral Hospital in Eldoret, Western Kenya. The first of its kind in Eastern Africa, it has met with success in the retention of highly qualified practitioners providing complex pregnancy care to a population that has been heretofore underserved.

中低收入国家在亚专科护理方面资源不足。本研究介绍了肯尼亚西部埃尔多雷特的莫伊大学医学院和莫伊教学与转诊医院开展的一项独特的母胎医学临床奖学金培训计划。该项目是东非首个此类项目,成功留住了高素质的从业人员,为迄今为止服务不足的人群提供复杂的孕期保健服务。
{"title":"Improving health equity through sustained academic partnership: development of a maternal-fetal medicine fellowship training program in Western Kenya","authors":"David Nding'ori MMed ,&nbsp;Rachel F. Spitzer MD, MPH ,&nbsp;Julia Songok MMed ,&nbsp;Marie Buitendyk MD, MSc ,&nbsp;Pallavi Mishra MMed ,&nbsp;Wycliffe Kosgei MMed ,&nbsp;Bett Kipchumba MMed ,&nbsp;Mutindi Kakuti MMed ,&nbsp;Philip Tonui MMed ,&nbsp;Karen Fung-Kee-Fung MD, MHPE ,&nbsp;Heidi Leftwich DO ,&nbsp;Adrian Gardner MD, MPH ,&nbsp;Paul Nyongesa MMed ,&nbsp;Nanette Okun MD, MHsc","doi":"10.1016/j.xagr.2024.100362","DOIUrl":"10.1016/j.xagr.2024.100362","url":null,"abstract":"<div><p>Low- and middle-income countries are underresourced in subspecialist care. This study describes a unique maternal-fetal medicine clinical fellowship training program at Moi University School of Medicine and Moi Teaching and Referral Hospital in Eldoret, Western Kenya. The first of its kind in Eastern Africa, it has met with success in the retention of highly qualified practitioners providing complex pregnancy care to a population that has been heretofore underserved.</p></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"4 3","pages":"Article 100362"},"PeriodicalIF":0.0,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266657782400056X/pdfft?md5=91f02a3750508b02a6cd5453b2f1e830&pid=1-s2.0-S266657782400056X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141415023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The United States landscape of global women's health fellowship training programs 美国全球妇女健康研究金培训计划的现状
Pub Date : 2024-06-12 DOI: 10.1016/j.xagr.2024.100363
Dhanalakshmi K. Thiyagarajan MD, Evan Keil MD, Kati Shanks BSN, Maeve Sullivan BS, Emma R. Lawrence MD, MS
{"title":"The United States landscape of global women's health fellowship training programs","authors":"Dhanalakshmi K. Thiyagarajan MD,&nbsp;Evan Keil MD,&nbsp;Kati Shanks BSN,&nbsp;Maeve Sullivan BS,&nbsp;Emma R. Lawrence MD, MS","doi":"10.1016/j.xagr.2024.100363","DOIUrl":"10.1016/j.xagr.2024.100363","url":null,"abstract":"","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"4 3","pages":"Article 100363"},"PeriodicalIF":0.0,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000571/pdfft?md5=a31f88daedd7c030af817ec5e3026137&pid=1-s2.0-S2666577824000571-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141414076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An analysis of oral contraceptive related videos on TikTok 对 TikTok 上口服避孕药相关视频的分析
Pub Date : 2024-06-12 DOI: 10.1016/j.xagr.2024.100364
Melanie Shackleford MD , Anna Horvath BS , Mayra Repetto BS , Andrea Thi BS , Rory Twells BS , Maggie Sanders BS , Stephanie Fernandez BS , Dale Netski PhD , Kavita Batra PhD, MPH, BDS, FRSPH , Nadia Gomez MD, MBA , Leanne Free MD, MSCS

Background

TikTok has increasingly become a source of information about reproductive health. Patients seeking health information about oral contraception on TikTok may be influenced by videos containing misinformation or biased information.

Objective

This social media infodemiological study aims to provide a descriptive content analysis of the quality and reliability of oral contraceptive health information on TikTok.

Study Design

Researchers screened 1,000 TikTok videos from December 2022 to March 2023 retrieved under various search terms related to oral contraceptives. Data, including engagement metrics such as views, likes, comments, saves, and shares, were recorded. Video content including contraceptive methods discussed, efficacy, tolerability, and side effects were recorded. Two reviewers independently used a modified DISCERN criteria and Global Quality Scale (GQS) to assess the quality and reliability of information for each video.

Results

Five hundred seventy-four videos were analyzed after applying exclusion criteria. Videos had a median length of 27 seconds (Q1=13sec, Q3=57sec) and received a median of 35,000 total views (Q1=4856 views, Q3=411,400 views) and 166 views per day (Q1=28 views per day, Q3=2021 views per day). Video creators were 83.3% female and 58.7% white. The mean modified DISCERN score was 1.63 (SD=1.06) and the mean GQS score was 2.28 (SD=1.37). Video creators were 83.3% female and 58.7% white. The mean modified DISCERN score was 1.63 (SD=1.06) and the mean GQS score was 2.28 (SD=1.37). The most common topic discussed in the videos was the effects of contraception. Healthcare professionals had significantly higher DISCERN and GQS scores (p<.001) than non-healthcare professionals. However, they received fewer views, likes, and comments on their videos (p<.001). Healthcare professionals were 86 times more likely than non-healthcare professionals to post educational videos (p<.001). However, non-educational content received significantly more views, likes, and comments than educational content (p<.001).

Conclusion

TikTok videos related to oral contraceptive health had low quality and reliability of information. The majority of videos were made by non-healthcare providers, and the most common topic discussed was the effects of contraception. Videos made by healthcare professionals contained more reliable contraceptive information, but received less engagement than videos made by non-healthcare professionals. Healthcare providers should consider the prevalence of poor-quality information about oral contraceptives on social media when counseling and educating patients about reproductive health.

背景TikTok日益成为生殖健康信息的来源。在 TikTok 上寻求口服避孕药健康信息的患者可能会受到含有错误信息或偏差信息的视频的影响。研究设计研究人员筛选了 2022 年 12 月至 2023 年 3 月期间根据与口服避孕药相关的各种搜索词检索到的 1,000 个 TikTok 视频。研究人员记录了包括浏览量、点赞数、评论数、保存数和分享数等参与度指标在内的数据。记录的视频内容包括讨论的避孕方法、疗效、耐受性和副作用。两名审查员独立使用修改后的 DISCERN 标准和全球质量量表 (GQS) 评估每个视频的信息质量和可靠性。视频长度的中位数为 27 秒(Q1=13 秒,Q3=57 秒),总浏览量的中位数为 35,000 次(Q1=4856 次,Q3=411,400 次),日浏览量为 166 次(Q1=28 次/日,Q3=2021 次/日)。视频创作者中 83.3% 为女性,58.7% 为白人。修改后的 DISCERN 平均得分为 1.63(标准差=1.06),GQS 平均得分为 2.28(标准差=1.37)。视频创作者中 83.3% 为女性,58.7% 为白人。修正后的 DISCERN 平均得分为 1.63(标准差=1.06),GQS 平均得分为 2.28(标准差=1.37)。视频中最常讨论的话题是避孕效果。医护人员的 DISCERN 和 GQS 得分(p<.001)明显高于非医护人员。但是,他们的视频获得的浏览量、点赞和评论数量都较少(p< .001)。医疗保健专业人员发布教育视频的可能性是非医疗保健专业人员的 86 倍(p< .001)。然而,非教育性内容获得的浏览量、点赞数和评论数都明显高于教育性内容(p< .001)。大多数视频是由非医疗保健提供者制作的,最常讨论的话题是避孕效果。医疗保健专业人员制作的视频包含更可靠的避孕信息,但与非医疗保健专业人员制作的视频相比,参与度较低。医疗保健提供者在为患者提供生殖健康咨询和教育时,应考虑到社交媒体上关于口服避孕药的劣质信息的普遍性。
{"title":"An analysis of oral contraceptive related videos on TikTok","authors":"Melanie Shackleford MD ,&nbsp;Anna Horvath BS ,&nbsp;Mayra Repetto BS ,&nbsp;Andrea Thi BS ,&nbsp;Rory Twells BS ,&nbsp;Maggie Sanders BS ,&nbsp;Stephanie Fernandez BS ,&nbsp;Dale Netski PhD ,&nbsp;Kavita Batra PhD, MPH, BDS, FRSPH ,&nbsp;Nadia Gomez MD, MBA ,&nbsp;Leanne Free MD, MSCS","doi":"10.1016/j.xagr.2024.100364","DOIUrl":"10.1016/j.xagr.2024.100364","url":null,"abstract":"<div><h3>Background</h3><p>TikTok has increasingly become a source of information about reproductive health. Patients seeking health information about oral contraception on TikTok may be influenced by videos containing misinformation or biased information.</p></div><div><h3>Objective</h3><p>This social media infodemiological study aims to provide a descriptive content analysis of the quality and reliability of oral contraceptive health information on TikTok.</p></div><div><h3>Study Design</h3><p>Researchers screened 1,000 TikTok videos from December 2022 to March 2023 retrieved under various search terms related to oral contraceptives. Data, including engagement metrics such as views, likes, comments, saves, and shares, were recorded. Video content including contraceptive methods discussed, efficacy, tolerability, and side effects were recorded. Two reviewers independently used a modified DISCERN criteria and Global Quality Scale (GQS) to assess the quality and reliability of information for each video.</p></div><div><h3>Results</h3><p>Five hundred seventy-four videos were analyzed after applying exclusion criteria. Videos had a median length of 27 seconds (Q1=13sec, Q3=57sec) and received a median of 35,000 total views (Q1=4856 views, Q3=411,400 views) and 166 views per day (Q1=28 views per day, Q3=2021 views per day). Video creators were 83.3% female and 58.7% white. The mean modified DISCERN score was 1.63 (SD=1.06) and the mean GQS score was 2.28 (SD=1.37). Video creators were 83.3% female and 58.7% white. The mean modified DISCERN score was 1.63 (SD=1.06) and the mean GQS score was 2.28 (SD=1.37). The most common topic discussed in the videos was the effects of contraception. Healthcare professionals had significantly higher DISCERN and GQS scores (<em>p</em>&lt;.001) than non-healthcare professionals. However, they received fewer views, likes, and comments on their videos (<em>p</em>&lt;.001). Healthcare professionals were 86 times more likely than non-healthcare professionals to post educational videos (<em>p</em>&lt;.001). However, non-educational content received significantly more views, likes, and comments than educational content (<em>p</em>&lt;.001).</p></div><div><h3>Conclusion</h3><p>TikTok videos related to oral contraceptive health had low quality and reliability of information. The majority of videos were made by non-healthcare providers, and the most common topic discussed was the effects of contraception. Videos made by healthcare professionals contained more reliable contraceptive information, but received less engagement than videos made by non-healthcare professionals. Healthcare providers should consider the prevalence of poor-quality information about oral contraceptives on social media when counseling and educating patients about reproductive health.</p></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"4 3","pages":"Article 100364"},"PeriodicalIF":0.0,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000583/pdfft?md5=5f992e9207e8a384ef1eabae2ed8b761&pid=1-s2.0-S2666577824000583-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141404202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal obesity alters fetal neuroinflammation in a murine model of preterm birth 在早产小鼠模型中,母体肥胖会改变胎儿的神经炎症。
Pub Date : 2024-06-12 DOI: 10.1016/j.xagr.2024.100361
Katherine M. Leonard DO , Stacey S. Schmiedecke MD , Rebecca L. Talley BS , Jennifer R. Damicis BS , Robert B. Walton MD , Irina Burd MD, PhD , Peter G. Napolitano MD , Nicholas Ieronimakis PhD

BACKGROUND

Preterm birth from intrauterine infection is a leading cause of neonatal neurologic morbidity. Likewise, maternal obesity is associated with intra-amniotic infection and inflammation. Whether maternal obesity is a risk factor for fetal brain injury that occurs with premature birth remains unknown. This study hypothesized that maternal obesity intensifies fetal neuroinflammation in the setting of premature delivery.

OBJECTIVE

This study aimed to examine the influence of maternal obesity on perinatal neuroinflammatory responses that arise with preterm birth using a murine model.

STUDY DESIGN

Dams with obesity were generated via a high-fat diet that was maintained throughout pregnancy. In parallel, dams without obesity (normal) received a control diet. All dams were paired with males on normal diet. Pregnant dams were randomized to receive an intrauterine administration of bacterial endotoxin (lipopolysaccharide) or the vehicle (phosphate-buffered saline) on embryo day 15.5 of what is typically a 19- to 21-day gestation. Fetal brains were harvested 6 hours after intrauterine administrations, and the expressions of key inflammatory cytokines (Il1b, Il6, and Tnf) and panels of metabolic, immune, and inflammatory genes were analyzed.

RESULTS

With the phosphate-buffered saline, there was no difference in gene expression related to maternal obesity. There were substantial differences in Il6 and immune/inflammatory expression profiles in fetal brains from dams with obesity vs normal dams that received lipopolysaccharide. Few differences were observed among the metabolic genes examined under these conditions. The gene expression pattern associated with maternal obesity correlated with pathways related to white matter injury.

CONCLUSION

The expression of neuroinflammatory markers instigated by bacterial endotoxin via intrauterine lipopolysaccharide was greater in embryo brains obtained from dams with obesity. Expression profiles suggest that in combination with intrauterine inflammation, maternal obesity may increase the risk of fetal white matter injury. Further investigation is warranted to understand the relationship between maternal health and neurologic outcomes associated with prematurity.

背景宫内感染导致的早产是新生儿神经系统发病的主要原因。同样,产妇肥胖也与羊膜腔内感染和炎症有关。孕产妇肥胖是否是早产导致胎儿脑损伤的风险因素仍是未知数。本研究假设,在早产的情况下,母体肥胖会加剧胎儿的神经炎症。研究设计肥胖的母体是通过在整个孕期维持高脂肪饮食而产生的。与此同时,未患肥胖症的母鼠(正常)接受对照饮食。所有母鼠都与正常饮食的雄鼠配对。怀孕母鼠被随机分配到接受细菌内毒素(脂多糖)或载体(磷酸盐缓冲盐水)的子宫内给药,给药时间为胚胎发育的第15.5天,通常为妊娠期的19-21天。宫内给药 6 小时后采集胎儿大脑,分析关键炎症细胞因子(Il1b、Il6 和 Tnf)以及代谢、免疫和炎症基因的表达。肥胖母体与接受脂多糖的正常母体相比,胎儿大脑中的Il6和免疫/炎症基因表达谱存在很大差异。在这些条件下,几乎没有观察到代谢基因之间的差异。结论 通过宫内脂多糖细菌内毒素引起的神经炎症标记物在肥胖母体胚胎大脑中的表达量更大。表达谱表明,母体肥胖与宫内炎症相结合,可能会增加胎儿白质损伤的风险。要了解孕产妇健康与早产相关神经系统结果之间的关系,还需要进一步的研究。
{"title":"Maternal obesity alters fetal neuroinflammation in a murine model of preterm birth","authors":"Katherine M. Leonard DO ,&nbsp;Stacey S. Schmiedecke MD ,&nbsp;Rebecca L. Talley BS ,&nbsp;Jennifer R. Damicis BS ,&nbsp;Robert B. Walton MD ,&nbsp;Irina Burd MD, PhD ,&nbsp;Peter G. Napolitano MD ,&nbsp;Nicholas Ieronimakis PhD","doi":"10.1016/j.xagr.2024.100361","DOIUrl":"10.1016/j.xagr.2024.100361","url":null,"abstract":"<div><h3>BACKGROUND</h3><p>Preterm birth from intrauterine infection is a leading cause of neonatal neurologic morbidity. Likewise, maternal obesity is associated with intra-amniotic infection and inflammation. Whether maternal obesity is a risk factor for fetal brain injury that occurs with premature birth remains unknown. This study hypothesized that maternal obesity intensifies fetal neuroinflammation in the setting of premature delivery.</p></div><div><h3>OBJECTIVE</h3><p>This study aimed to examine the influence of maternal obesity on perinatal neuroinflammatory responses that arise with preterm birth using a murine model.</p></div><div><h3>STUDY DESIGN</h3><p>Dams with obesity were generated via a high-fat diet that was maintained throughout pregnancy. In parallel, dams without obesity (normal) received a control diet. All dams were paired with males on normal diet. Pregnant dams were randomized to receive an intrauterine administration of bacterial endotoxin (lipopolysaccharide) or the vehicle (phosphate-buffered saline) on embryo day 15.5 of what is typically a 19- to 21-day gestation. Fetal brains were harvested 6 hours after intrauterine administrations, and the expressions of key inflammatory cytokines (<em>Il1b, Il6</em>, and <em>Tnf</em>) and panels of metabolic, immune, and inflammatory genes were analyzed.</p></div><div><h3>RESULTS</h3><p>With the phosphate-buffered saline, there was no difference in gene expression related to maternal obesity. There were substantial differences in <em>Il6</em> and immune/inflammatory expression profiles in fetal brains from dams with obesity vs normal dams that received lipopolysaccharide. Few differences were observed among the metabolic genes examined under these conditions. The gene expression pattern associated with maternal obesity correlated with pathways related to white matter injury.</p></div><div><h3>CONCLUSION</h3><p>The expression of neuroinflammatory markers instigated by bacterial endotoxin via intrauterine lipopolysaccharide was greater in embryo brains obtained from dams with obesity. Expression profiles suggest that in combination with intrauterine inflammation, maternal obesity may increase the risk of fetal white matter injury. Further investigation is warranted to understand the relationship between maternal health and neurologic outcomes associated with prematurity.</p></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"4 3","pages":"Article 100361"},"PeriodicalIF":0.0,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000558/pdfft?md5=fb9d05358dff8e61ed7acd1bc3de2490&pid=1-s2.0-S2666577824000558-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141398671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inconsistent definitions of prolonged labor in international literature: a scoping review 国际文献中关于分娩时间过长的定义不一致:范围审查
Pub Date : 2024-06-05 DOI: 10.1016/j.xagr.2024.100360
Wouter Bakker MD, PhD , Evelien M. Sandberg MD, PhD , Sharon Keetels BSc , Jan W. Schoones MA , Monica Lauridsen Kujabi MD, PhD , Nanna Maaløe MD, PhD , Salome Maswime MBChB, PhD , Thomas van den Akker MD, PhD

Objective

Prolonged labor is the commonest indication for intrapartum cesarean section, but definitions are inconsistent and some common definitions were recently found to overestimate the speed of physiological labor. The objective of this review is to establish an overview of synonyms and definitions used in the literature for prolonged labor, separated into first and second stages, and establish types of definitions used.

Data sources

A systematic search was conducted in PubMed, Embase, Web of Science, Cochrane Library, Emcare, and Academic Search Premier.

Study eligibility criteria

All articles in English that (1) attempted to define prolonged labor, (2) included a definition of prolonged labor, or (3) included any synonym for prolonged labor, were included.

Methods

Data on study design, year of publication, country or region of origin, synonyms used, definition of prolonged first and/or second stage, and origin of provided definition (if not primarily established by the study) were collected into a database.

Results

In total, 3402 abstracts and 536 full-text papers were screened, and 232 papers were included. Our search established 53 synonyms for prolonged labor. Forty-three studies defined prolonged labor and 189 studies adopted a definition of prolonged labor. Definitions for prolonged first stage of labor were categorized into: time-based (n=14), progress-based (n=12), clinician-based (n=5), or outcome-based (n=4). For the 33 studies defining prolonged second stage, the majority of definitions (n=25) were time-based, either based on total duration or duration of no descent of the presenting part.

Conclusions

Despite efforts to arrive at uniform labor curves, there is still little uniformity in definitions of prolonged labor. Consensus on which definition to use is called for, in order to safely and respectfully allow physiological labor progress, ensure timely management, and assess and compare incidence of prolonged labor between settings.

目的延长产程是产中剖宫产的最常见指征,但定义并不一致,最近发现一些常见定义高估了生理性产程的速度。数据来源在PubMed、Embase、Web of Science、Cochrane Library、Emcare和Academic Search Premier中进行了系统检索。研究资格标准纳入所有(1)试图定义产程延长、(2)包含产程延长定义或(3)包含任何产程延长同义词的英文文章。方法在数据库中收集有关研究设计、发表年份、来源国家或地区、使用的同义词、第一和/或第二产程延长的定义以及所提供定义的来源(如果并非主要由研究确定)的数据。结果共筛选出 3402 篇摘要和 536 篇全文论文,并纳入 232 篇论文。通过检索,我们确定了 53 个 "产程延长 "的同义词。43项研究对产程延长进行了定义,189项研究采用了产程延长的定义。第一产程延长的定义分为:基于时间(14 篇)、基于进展(12 篇)、基于临床医生(5 篇)或基于结果(4 篇)。在定义第二产程延长的 33 项研究中,大多数定义(n=25)是基于时间的,要么基于总持续时间,要么基于出现部位无下降的持续时间。我们需要就使用哪种定义达成共识,以便安全、尊重地允许生理性产程进展,确保及时处理,并评估和比较不同环境下的产程延长发生率。
{"title":"Inconsistent definitions of prolonged labor in international literature: a scoping review","authors":"Wouter Bakker MD, PhD ,&nbsp;Evelien M. Sandberg MD, PhD ,&nbsp;Sharon Keetels BSc ,&nbsp;Jan W. Schoones MA ,&nbsp;Monica Lauridsen Kujabi MD, PhD ,&nbsp;Nanna Maaløe MD, PhD ,&nbsp;Salome Maswime MBChB, PhD ,&nbsp;Thomas van den Akker MD, PhD","doi":"10.1016/j.xagr.2024.100360","DOIUrl":"10.1016/j.xagr.2024.100360","url":null,"abstract":"<div><h3>Objective</h3><p>Prolonged labor is the commonest indication for intrapartum cesarean section, but definitions are inconsistent and some common definitions were recently found to overestimate the speed of physiological labor. The objective of this review is to establish an overview of synonyms and definitions used in the literature for prolonged labor, separated into first and second stages, and establish types of definitions used.</p></div><div><h3>Data sources</h3><p>A systematic search was conducted in PubMed, Embase, Web of Science, Cochrane Library, Emcare, and Academic Search Premier.</p></div><div><h3>Study eligibility criteria</h3><p>All articles in English that (1) attempted to define prolonged labor, (2) included a definition of prolonged labor, or (3) included any synonym for prolonged labor, were included.</p></div><div><h3>Methods</h3><p>Data on study design, year of publication, country or region of origin, synonyms used, definition of prolonged first and/or second stage, and origin of provided definition (if not primarily established by the study) were collected into a database.</p></div><div><h3>Results</h3><p>In total, 3402 abstracts and 536 full-text papers were screened, and 232 papers were included. Our search established 53 synonyms for prolonged labor. Forty-three studies defined prolonged labor and 189 studies adopted a definition of prolonged labor. Definitions for prolonged first stage of labor were categorized into: time-based (<em>n</em>=14), progress-based (<em>n</em>=12), clinician-based (<em>n</em>=5), or outcome-based (<em>n</em>=4). For the 33 studies defining prolonged second stage, the majority of definitions (<em>n</em>=25) were time-based, either based on total duration or duration of no descent of the presenting part.</p></div><div><h3>Conclusions</h3><p>Despite efforts to arrive at uniform labor curves, there is still little uniformity in definitions of prolonged labor. Consensus on which definition to use is called for, in order to safely and respectfully allow physiological labor progress, ensure timely management, and assess and compare incidence of prolonged labor between settings.</p></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"4 3","pages":"Article 100360"},"PeriodicalIF":0.0,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000546/pdfft?md5=ded5482cccdfb58b7de5142cd6013755&pid=1-s2.0-S2666577824000546-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141396586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
sFlt1/PlGF among patients with suspected preeclampsia when considering hypertensive status 考虑高血压状态时,疑似子痫前期患者的 sFlt1/PlGF
Pub Date : 2024-05-27 DOI: 10.1016/j.xagr.2024.100359
Easha Patel MD , Sunitha Suresh MD , Ariel Mueller MA , Courtney Bisson MD , Katherine Zhu MD , Stefan Verlohren MD, PhD , Peter Von Dadelszen MBChB, DPhil , Laura Magee MD , Sarosh Rana MD, MPH

BACKGROUND

In high-resource settings, biomarkers of angiogenic balance, such as the soluble fms-like tyrosine kinase-1 (sFlt1)/placental growth factor (PlGF) ratio, have been studied extensively to aid in evaluation of patients with suspected preeclampsia (PE), and have been incorporated into the 2021 International Society for the Study of Hypertension in Pregnancy definition of PE. The utility in under-resourced settings has not been as well characterized.

OBJECTIVE

This analysis sought to identify the role of the sFlt1/PlGF ratio in the evaluation of patients with or without hypertension who are suspected of having PE without other diagnostic information.

STUDY DESIGN

This is a secondary analysis of a prior prospective study of patients who were presented with suspected PE at ≥20+0 weeks’ gestation at a single academic tertiary care center. Patients were recruited in the parent study from July 2009 to June 2012. In the original study, clinicians were masked to biomarker results, and patients were followed by chart review. In this analysis, the performance of the sFlt1/PlGF ratio (≤38, >38, or >85) was assessed alone in identifying both hypertensive and non-hypertensive patients at risk of evolving into PE with severe features (PE-SF; American College of Obstetricians and Gynecologists’ definition) within two weeks of the triage visit (PE-SF2). Hypertension was defined as a blood pressure (BP)≥140/90 mmHg.

RESULTS

There were 1043 patients included in the analysis; of whom, 579 (55.5%) and 464 (44.5%) presented with or without hypertension, respectively. In triage, 332 (75.4%) of hypertensive patients presented due to BP concerns, and the remainder were evaluated due to other features (new-onset headache, proteinuria, or edema). On triage evaluation, 66.8% of all patients had a normal sFlt1/PlGF ratio ≤38, and 17.0% had an elevated ratio >85. Among hypertensive patients, a sFlt1/PlGF ratio ≤38 was a good rule-out test for PE-SF2 (negative likelihood ratio [LR-] of 0.15), and a ratio >85 was a good rule-in test (positive likelihood ratio [LR+] of 5.75). Among normotensive patients, sFlt1/PlGF was useful as a rule-in test for ratio >38 (LR+ 5.13) and >85 (LR+ 12.80). Stratified by gestational age, sFlt1/PlGF continued to be a good rule in and good rule out test at <35 weeks among those with hypertension but did not have good test performance ≥35 weeks. sFlt1/PlGF had a good test performance as a rule in test for >85 regardless of gestational age. In triage, 4.3% (30/693) of patients with sFlt1/PlGF ratio <38 had concurrent laboratory evidence of PE, compared with 15.9% (28/176) patients with ratio >85.

CONCLUSION

These findings support the potential for the use of sFlt1/PlGF and BP measurement alone in resource-limited settings where other laboratory tests or clinical expertise are u

背景在资源丰富的环境中,血管生成平衡的生物标志物,如可溶性酪氨酸激酶-1(sFlt1)/胎盘生长因子(PlGF)比值,已被广泛研究用于帮助评估疑似子痫前期(PE)患者,并已被纳入2021年国际妊娠高血压研究学会对PE的定义中。本分析旨在确定 sFlt1/PlGF 比值在评估有或无高血压但无其他诊断信息的疑似 PE 患者中的作用。研究设计这是对之前一项前瞻性研究的二次分析,该研究的对象是在一家学术性三级医疗中心就诊的妊娠≥20+0 周疑似 PE 患者。母研究从 2009 年 7 月至 2012 年 6 月招募患者。在最初的研究中,临床医生对生物标记物结果进行了蒙蔽,并通过病历审查对患者进行了随访。在这项分析中,仅评估了 sFlt1/PlGF 比值(≤38、38 或 85)在识别高血压和非高血压患者方面的性能,这些患者在分诊后两周内有可能演变为具有严重特征的 PE(PE-SF;美国妇产科医师学会的定义)(PE-SF2)。结果共有 1043 名患者纳入分析,其中分别有 579 人(55.5%)和 464 人(44.5%)患有或不患有高血压。在分诊过程中,332 名(75.4%)高血压患者因血压问题就诊,其余患者因其他特征(新发头痛、蛋白尿或水肿)接受评估。在分诊评估时,66.8% 的患者 sFlt1/PlGF 比值正常,≤38;17.0% 的患者 sFlt1/PlGF 比值升高至 85。在高血压患者中,sFlt1/PlGF 比值≤38 是排除 PE-SF2 的良好检测指标(阴性似然比 [LR-] 为 0.15),而比值>85 是排除 PE-SF2 的良好检测指标(阳性似然比 [LR+] 为 5.75)。在血压正常的患者中,sFlt1/PlGF可作为比值比>38(LR+ 5.13)和>85(LR+ 12.80)的规则入选检验。根据胎龄分层,sFlt1/PlGF 在 35 周时仍是高血压患者的入选标准和排除标准,但在≥35 周时则没有良好的测试性能。在分诊中,4.3%(30/693)的 sFlt1/PlGF 比率为 <38的患者同时有 PE 的实验室证据,而比率为 >85的患者为 15.9%(28/176)。生物标志物的性能因是否存在高血压和胎龄而异。
{"title":"sFlt1/PlGF among patients with suspected preeclampsia when considering hypertensive status","authors":"Easha Patel MD ,&nbsp;Sunitha Suresh MD ,&nbsp;Ariel Mueller MA ,&nbsp;Courtney Bisson MD ,&nbsp;Katherine Zhu MD ,&nbsp;Stefan Verlohren MD, PhD ,&nbsp;Peter Von Dadelszen MBChB, DPhil ,&nbsp;Laura Magee MD ,&nbsp;Sarosh Rana MD, MPH","doi":"10.1016/j.xagr.2024.100359","DOIUrl":"https://doi.org/10.1016/j.xagr.2024.100359","url":null,"abstract":"<div><h3>BACKGROUND</h3><p>In high-resource settings, biomarkers of angiogenic balance, such as the soluble fms-like tyrosine kinase-1 (sFlt1)/placental growth factor (PlGF) ratio, have been studied extensively to aid in evaluation of patients with suspected preeclampsia (PE), and have been incorporated into the 2021 International Society for the Study of Hypertension in Pregnancy definition of PE. The utility in under-resourced settings has not been as well characterized.</p></div><div><h3>OBJECTIVE</h3><p>This analysis sought to identify the role of the sFlt1/PlGF ratio in the evaluation of patients with or without hypertension who are suspected of having PE without other diagnostic information.</p></div><div><h3>STUDY DESIGN</h3><p>This is a secondary analysis of a prior prospective study of patients who were presented with suspected PE at ≥20+0 weeks’ gestation at a single academic tertiary care center. Patients were recruited in the parent study from July 2009 to June 2012. In the original study, clinicians were masked to biomarker results, and patients were followed by chart review. In this analysis, the performance of the sFlt1/PlGF ratio (≤38, &gt;38, or &gt;85) was assessed alone in identifying both hypertensive and non-hypertensive patients at risk of evolving into PE with severe features (PE-SF; American College of Obstetricians and Gynecologists’ definition) within two weeks of the triage visit (PE-SF<sub>2</sub>). Hypertension was defined as a blood pressure (BP)≥140/90 mmHg.</p></div><div><h3>RESULTS</h3><p>There were 1043 patients included in the analysis; of whom, 579 (55.5%) and 464 (44.5%) presented with or without hypertension, respectively. In triage, 332 (75.4%) of hypertensive patients presented due to BP concerns, and the remainder were evaluated due to other features (new-onset headache, proteinuria, or edema). On triage evaluation, 66.8% of all patients had a normal sFlt1/PlGF ratio ≤38, and 17.0% had an elevated ratio &gt;85. Among hypertensive patients, a sFlt1/PlGF ratio ≤38 was a good rule-out test for PE-SF<sub>2</sub> (negative likelihood ratio [LR-] of 0.15), and a ratio &gt;85 was a good rule-in test (positive likelihood ratio [LR+] of 5.75). Among normotensive patients, sFlt1/PlGF was useful as a rule-in test for ratio &gt;38 (LR+ 5.13) and &gt;85 (LR+ 12.80). Stratified by gestational age, sFlt1/PlGF continued to be a good rule in and good rule out test at &lt;35 weeks among those with hypertension but did not have good test performance ≥35 weeks. sFlt1/PlGF had a good test performance as a rule in test for &gt;85 regardless of gestational age. In triage, 4.3% (30/693) of patients with sFlt1/PlGF ratio &lt;38 had concurrent laboratory evidence of PE, compared with 15.9% (28/176) patients with ratio &gt;85.</p></div><div><h3>CONCLUSION</h3><p>These findings support the potential for the use of sFlt1/PlGF and BP measurement alone in resource-limited settings where other laboratory tests or clinical expertise are u","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"4 3","pages":"Article 100359"},"PeriodicalIF":0.0,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000534/pdfft?md5=a1ddd6b1d8b08397f37a51c700aa7e7f&pid=1-s2.0-S2666577824000534-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141423847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
AJOG global reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1